Fig. 1From: The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionRepresentative pictures of SENP1 immunostaining in prostate cancer with a) negative, b) weak, c) moderate, and d) strong stainingBack to article page